Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function

Annals of the New York Academy of Sciences

Volumn 1266, Issue 1, 2012, Pages 151-160

  Broxmeyer, Hal E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cord blood; Cytokines; Intracellular signals; Stem and progenitor cells

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ANGIOPOIETIN; ANGIOPOIETIN 2; CHEMOKINE RECEPTOR CXCR4; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; FLT3 LIGAND; GROWTH FACTOR; INTERLEUKIN 21; INTERLEUKIN 22; LEUKEMIA INHIBITORY FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; OCTAMER TRANSCRIPTION FACTOR 4; ONCOSTATIN M; PROTEIN BCL 6; PROTEIN P21; PROTEIN P53; RECOMBINANT THROMBOPOIETIN; SIRTUIN 1; STAT4 PROTEIN; STAT6 PROTEIN; THROMBOPOIETIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; CYTOKINE PRODUCTION; ENGRAFTMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE;

EID: 84865365341     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06509.x     Document Type: Article

References (122)

1. Broxmeyer, H.E., G.W. Douglas, G. Hangoc, et al 1989. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86: 3828-3832.
2. Broxmeyer, H.E., E. Gluckman, A. Auerbach, et al 1990. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int. J. Cell Cloning 8(Suppl. 1): 76-91.
3. Auerbach, A.D., Q. Liu, R. Ghosh, et al 1990. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi Anemia. Transfusion 30: 682-687.
4. Pollack, M.S., A.D. Auerbach, H.E. Broxmeyer, et al 1991. The use of DNA amplification for DQ typing as an adjunct to serological prenatal HLA typing for the identification of potential donors for umbilical cord blood transplantation. Human Immunol. 30: 45-49.
5. Broxmeyer, H.E., J. Kurtzberg, E. Gluckman, et al 1991. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation. Blood Cells 17: 313-329.
6. Carow, C., G. Hangoc, S. Cooper, et al 1991. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential (CFU-GEMM) progenitor cells with a high replating potential. Blood 78: 2216-2221.
7. Broxmeyer, H.E., G. Hangoc, S. Cooper, et al 1992. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation of adults. Proc. Natl. Acad. Sci. USA 89: 4109-4113.
8. Carow, C.E., G. Hangoc & H.E. Broxmeyer 1993. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma. Blood 81: 942-949.
9. +++ human umbilical cord blood hematopoietic progenitor with high proliferative and replating potential. Blood 81: 41-48.
10. Gluckman, E., H.E. Broxmeyer, A.D. Auerbach, et al 1989. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling. New Engl. J. Med. 321: 1174-1178.
11. Wagner, J.E., H.E. Broxmeyer, R.L. Byrd, et al 1992. Transplantation of umbilical cord blood after myeloblative therapy: analysis of engraftment. Blood 79: 1874-1881.
12. Kohli-Kumar, M., N.T. Shahidi, H.E. Broxmeyer, et al 1993. Haematopoietic stem/progenitor cell transplant in Fanconi anemia using HLA-matched sibling umbilical cord blood cells. Brit. J. Haematol. 85: 419-422.
13. Wagner, J.E., N.A. Kernan, M. Steinbuch, et al 1995. Allogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease. Lancet 346: 214-219.
14. Broxmeyer, H.E. & F.O. Smith 2009. Cord blood hematopoietic cell transplantation. In Thomas' Hematopoietic Cell Transplantation, 4th ed. F.R. Appelbaum, S.J. Forman, R.S. Negrin & K.G. Blume, Eds.: 559-576. Wiley-Blackwell. West Sussex, UK
15. Rocha, V. & H.E. Broxmeyer 2009. New approaches for improving engraftment after cord blood transplantation. Biol. Blood Marrow Transplant. 16: S126-S132.
16. Rubinstein, P., R.E. Rosenfield, J.W. Adamson & C.E. Stevens 1993. Stored placental blood for unrelated bone marrow reconstitution. Blood 81: 1679-1690.
17. Rubinstein, P., L. Dobrila, R.E. Rosenfield, et al 1995. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc. Natl. Acad. Sci. USA 92: 10119-10122.
18. Guindi, E.S., T.F. Moss & M.T. Ernst 2011. Public and private cord blood banking. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 595-628. AABB Press. Bethesda, MD.
19. Regan, D.M. 2011. Cord blood banking: the development and application of cord blood banking processes, standards, and regulations. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 633-644. AABB Press. Bethesda, MD.
20. Sniecinski, I. 2011. Cord blood banking in developing countries. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 647-661. AABB Press. Bethesda, MD.
21. Boo, M., K. Welte & D. Confer 2011. Accreditation and regulation of cord blood banking. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 663-671. AABB Press. Bethesda, MD.
22. Welte, K., M. Boo & D. Confer 2011. Worldwide searching and distribution of cord blood units. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 673-684. AABB Press. Bethesda, MD.
23. Kurtzberg, J., M. Laughlin, M.L. Graham, et al 1996. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N. Engl. J. Med. 335: 157-166.
24. Wagner, J.E., J. Rosenthal, R. Sweetman, et al 1996. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88: 795-802.
25. Gluckman, E., V. Rocha, A. Boyer-Chammard, et al 1997. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 337: 373-381.
26. Rubinstein, P., C. Carrier, A. Scaradavou, et al 1998. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339: 1565-1577.
27. Rocha, V., J.E. Wagner Jr., K.A. Sobocinski, et al 2000. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N. Engl. J. Med. 342: 1846-1854.
28. Laughlin, M.J., J. Barker, B. Bambach, et al 2001. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med. 344: 1815-1822.
29. Rocha, V., J. Cornish, E.L. Sievers, et al 2001. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97: 2962-2971.
30. Wagner, J.E., J.N. Barker, T.E. Defor, et al 2002. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100: 1611-1618.
31. Barker, J.N., D.J. Weisdorf, T.E. Defor, et al 2003. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102: 1915-1919.
32. Rocha, V., M. Labopin, G. Sanz, et al 2004. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351: 2276-2285.
33. Laughlin, M.J., M. Eapen, P. Rubinstein, et al 2004. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl. J. Med. 351: 2265-2275.
34. Brunstein, C.G., J.N. Barker, D.J. Weisdorf, et al 2007. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110: 3064-3070.
35. Eapen, M., P. Rubinstein, M.J. Zhang, et al 2007. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369: 1947-1954.
36. Kurtzberg, J., V.K. Prasad, S.L. Carter, et al 2008. Results of the cord blood transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 112: 4318-4327.
37. Eapen, M., V. Rocha, G. Sanz, et al 2010. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 11: 653-660.
38. Eapen, M. 2011. Cord blood transplantation for leukemia in children. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 467-474. AABB Press. Bethesda, MD.
39. Horwitz, M.E. & N. Chao 2011. Umbilical cord blood transplantation for treatment of nonmalignant disorders. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 477-483. AABB Press. Bethesda, MD.
40. Gluckman, E., A. Ruggeri & V. Rocha 2011. Extending the use of cord blood cells to adults. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 487-499. AABB Press. Bethesda, MD.
41. Brunstein, C.G. & J.E. Wagner 2011. Double umbilical cord blood transplantation for malignant disorders. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 503-524. AABB Press. Bethesda, MD
42. Ponce, D.M. & J.N. Barker 2011. Determinants of engraftment after double-unit cord blood transplantation. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 529-541. AABB Press. Bethesda, MD.
43. Chen, Y.-B., C. Cutler & K. Ballen 2011. Reduced-intensity conditioning and double umbilical cord blood transplantation. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 545-553. AABB Press. Bethesda, MD.
44. McCullough, J. & D. McKenna 2011. Management of umbilical cord blood at the transplant center. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 585-592. AABB Press. Bethesda, MD.
45. Petz, L.D., S.R. Spellman & L. Gragert 2011. The underutilization of cord blood transplantation: extent of the problem, causes, and methods of improvement. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 557-581. AABB Press. Bethesda, MD.
46. Broxmeyer, H.E., S. Cooper, D.M. Haas, et al 2009. Experimental basis of cord blood transplantation. Bone Marrow Transplantation 44(Special Issue): 627-633.
47. Barker, J.N., D.J. Weisdorf, T.E. Defor, et al 2005. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105: 1343-1347.
48. Ballen, K.K., T.R. Spitzer, B.Y. Yeap, et al 2007. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol. Blood Marrow Transplant. 13: 82-89.
49. Brunstein, C.G., J.A. Gutman, D.J. Weisdorf, et al 2010. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 116: 4693-4699.
50. Cutler, C., K. Stevenson, H.T. Kim, et al 2011. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant. 46: 659-667.
51. Shpall, E.J., R. Quinones, R. Giller, et al 2002. Transplantation of ex vivo expanded cord blood. Biol. Blood Marrow Transplant. 8: 368-376.
52. Jaroscak, J., K. Goltry, A. Smith, et al 2003. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101: 5061-5067.
53. Delaney, C., S. Heimfeld, C. Brashem-Stein, et al 2010. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16: 232-236.
54. Delaney, C. 2011. Ex vivo expansion of cord blood stem and progenitor cells. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 215-224. AABB Press. Bethesda, MD.
55. Frassoni, F., F. Gualandi, M. Podesta, et al 2008. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 9: 831-839.
56. Brunstein, C.G., J.N. Barker, D.J. Weisdorf, et al 2009. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant. 43: 935-940.
57. Frassoni, F., M. Podesta, R. Varaldo, et al 2011. Intrabone transplantation of cord blood cells and the journey of hematopoietic cells. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 239-250. AABB Press. Bethesda, MD.
58. + progenitor cells. J. Immunol. 169: 7000-7008.
59. Christopherson, K.W. II, G. Hangoc, C. Mantel & H.E. Broxmeyer 2004. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305: 1000-1003.
60. Tian, C., J. Bagley, D. Forman & J. Iacomini 2006. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 13: 652-658.
61. Peranteau, W.H., M. Endo, O.O. Adibe, et al 2006. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 108: 4268-4274.
62. Wyss, B.K., A.F.W. Donnelly, D. Zhou, et al 2009. Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by Diprotin A. Exp. Hematol. 37: 814-823.
63. + cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Develop. 16: 347-354.
64. null immunodeficient mice. Stem Cells Dev. 16: 355-360.
65. + peripheral blood cells. Stem Cells Dev. 16: 361-370.
66. Farag, S.S. & H.E. Broxmeyer 2011. CD26 inhibition to enhance cord blood engraftment. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 203-210. AABB Press. Bethesda, MD.
67. North, T.E., W. Goessling, C.R. Walkley, et al 2007. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447: 1007-1011.
68. Hoggatt, J., P. Singh, J. Sampath & L.M. Pelus 2009. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 113: 5444-5455.
69. Durand, E.M. & L.I. Zon 2010. Newly emerging roles for prostaglandin E2 regulation of hematopoiesis and hematopoietic stem cell engraftment. Curr. Opin. Hematol. 17: 308-312.
70. 2 and other eicosanoid-based strategies to enhance engraftment. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 187-197. AABB Press. Bethesda, MD.
71. Xia, L., J.M. Mcdaniel, T. Yago, et al 2004. Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 104: 3091-3096.
72. Robinson, S.N., P.J. Simmons, P.A. Zweidler-McKay & E.J. Shpall 2011. Fucosylation for improved engraftment. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 227-234. AABB Press. Bethesda, MD.
73. Chitteti, B.R., M.A. Kacena & E.F. Srour 2011. Phenotypic characterization of hematopoietic stem cells. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 75-83. AABB Press. Bethesda, MD.
74. Cai, S., H. Wang & K.E. Pollok 2011. Immunodeficient mouse models for assessing human hematopoiesis. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 87-106. AABB Press. Bethesda, MD.
75. Notta, F., S. Doulatov, E. Laurenti, et al 2011. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333: 218-221.
76. Shaheen, M. & H.E. Broxmeyer 2009. The humoral regulation of hematopoiesis. In Hematology: Basic Principles and Practice, 5th ed. R. Hoffman, E.J. Benz Jr., S.J. Shattil, et al., Eds.: 253-275. Elsevier Churchill Livingston. Philadelphia, PA
77. Shaheen, M. & H.E. Broxmeyer 2011. Hematopoietic cytokines and growth factors. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 35-63. AABB Press. Bethesda, MD.
78. Chute J. 2011. Regulation of hematopoiesis by the bone marrow vascular niche. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 133-147. AABB Press. Bethesda, MD.
79. Lucas, D. & P.S. Frenette 2011. Cellular components and regulation of the hematopoietic stem cell niche. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 153-162. AABB Press. Bethesda, MD.
80. Kalinkovich, A., J. Canaani & T. Lapidot 2011. The dynamic and modifiable nature of hematopoietic stem cells and their niches. In Cord Blood Biology, Transplantation, Banking, and Regulation. H.E. Broxmeyer, Ed.: 169-182. AABB Press. Bethesda, MD.
81. Peled, A., I. Petit, O. Kollet, et al 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283: 845-848.
82. Broxmeyer, H.E., S. Cooper, L. Kohli, et al 2003. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J. Immunol. 170: 421-429.
83. Ivanova, N.B., J.T. Dimos, C. Schaniel, et al 2002. A stem cell molecular signature. Science 298: 601-604.
84. Campbell, T.B., S. Basu, G. Hangoc, et al 2009. Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation. Blood 114: 3392-3401.
85. + cells enhances their engraftment of NSG mice. Blood Cells Mol. Dis. 46: 318-320.
86. Liu, Y., J. Li, B.O. Kim, et al 2002. HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110. J. Biol. Chem. 277: 23854-23863.
87. Liu, Y., B.O. Kim, C. Kao, et al 2004. Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation. J. Biol. Chem. 279: 21766-21773.
88. Bell, M., S. Schreiner, A. Damianov, et al 2002. p110, a novel human U6 snRNP protein and U4/U6 snRNP recycling factor. EMBO J. 21: 2724-2735.
89. nrb/SART3/p110 regulation of hematopoiesis through c-Myc. Blood. 117: 5643-5651.
90. Liu, Y., M-R. Lee, K. Timani, et al 2012. Tip110 maintains expression of pluripotent factors in and pluripotency of human embryonic stem cells. Stem Cells Dev. 21(6): 829-833.
91. Frye, R.A. 2000. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Comm. 273: 793-798.
92. Haigis, M.C. & D.A. Sinclair 2010. Mammalian sirtuins: biological insights and disease relevance. Annual Rev. Pathol. 5: 253-295.
93. Han, M.-K., E.K. Song, Y. Guo, et al 2008. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2: 241-251.
94. Ou, X., H-D. Chae, R-H. Wang, et al 2011. SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood 117: 440-450.
95. Leko, V., B. Varnum-Finney, H. Li, et al 2012. SIRT1 is dispensable for function of hematopoietic stem cells in adult mice. Blood [Epub ahead of print January 4, 2012, doi: 10.1182/blood-2011-09-377077].
96. Chae, H-D. & H.E. Broxmeyer 2011. SIRT1 deficiency downregulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells. Stem Cells Dev. 20: 1277-1285.
97. Mantel, C., S. Messina-Graham & H.E. Broxmeyer 2010. Upregulation of nascent mitochondrial biogenesis in mouse hematopoietic stem cells parallels upregulation of CD34 and loss of pluripotency: a potential strategy for reducing oxidative risk in stem cells. Cell Cycle 9: 1-10.
98. Mantel, C., S. Messina-Graham, & H.E. Broxmeyer 2011. Superoxide flashes, ROS, and the mPTP: potential implications for hematopoietic stem cell function. Current Opin. Hematopoiesis 18: 208-213.
99. Mantel, C.R., R-H. Wang, C. Deng & H.E. Broxmeyer 2008. Sirt1, notch, and stem cell "age asymmetry." Cell Cycle 7: 2821-2825.
100. Chae, H.D., M.R. Lee & H.E. Broxmeyer 2012. AICAR induces G1/S arrest and enhances erythroid differentiation in mouse embryonic stem cells by modulating p53-Nanog pathways. Stem Cells 30: 140-149.
101. Waldmann, T., I. Scholten, F. Kappes, et al 2004. The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin. Gene 343: 1-9.
102. Kappes, F., T. Waldmann, V. Mathew, et al 2011. The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity. Genes Dev. 25: 673-678.
103. Mor-Vaknin, N., A. Punturieri, K. Sitwala, et al 2006. The DEK nuclear autoantigen is a secreted chemotactic factor. Mole. Cell Biol. 26: 9484-9496.
104. Broxmeyer, H.E., F. Kappas, N. Mor-Vaknin, et al 2011. DEK regulates hematopoietic stem cell engraftment and progenitor cell proliferation. Stem Cells Dev Oct 27 [Epub ahead of print, doi: 10.1089/scd.2011.0451.
105. cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 88: 3710-3719.
106. Cheng, T., N. Rodrigues, H. Shen, et al 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287: 1804-1808.
107. Stier, S., T. Cheng, R. Forkert, et al 2003. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 102: 1260-1266.
108. Shaheen M. & H.E. Broxmeyer In press. Principles of cytokine signaling. In Hematology: Basic Principles and Practice, 6th ed. R. Hoffman, E.J. Benz Jr, S.J. Shattil, et al., Eds. Elsevier Churchill Livingston. Philadelphia, PA
109. INK4C. Nat. Cell Biol. 6: 436-442.
110. KIP1. Stem Cells Dev.
111. Broxmeyer, H.E., H. Bruns, S. Zhang, et al 2002. Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity 16: 815-825.
112. Kaplan, M.H., C-H. Chang, S. Cooper, et al 2003. Distinct requirements for Stat4 and Stat6 in hematopoietic progenitor cell responses to growth factors and chemokines. J. Hematotherapy Stem Cell Res. 12: 401-408.
113. Broxmeyer, H.E., S. Sehra, S. Cooper, et al 2007. BAZF-deficient mice have unusual alterations in hematopoietic progenitor cell activity similar to that of BCL-6 deficient mice. Mole Cell Biol. 27: 5275-5285.
114. Kaplan, M.H., N.L. Glosson, G.L. Stritesky, et al 2011. STAT3-dependent IL-21 production from T cells regulates hematopoietic progenitor cell homeostasis. Blood 117: 6198-6201.
115. Zhang, C.C., M. Kaba, G. Ge, et al 2006. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat. Med. 12: 240-245.
116. Zhang, C.C., M. Kaba, S. Iizuka, et al 2008. Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111: 3415-3423.
117. Zheng, J., H. Huynh, M. Umikawa, et al 2011. Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Blood 117: 470-479.
118. Broxmeyer, H.E., E.F. Srour, S. Cooper, et al 2012. Angiopoietin-like-2 and -3 act through their coiled-coil domains to enhance survival and replating capacity of human cord blood hematopoietic progenitors. Blood Cells Mol. Dis. 48: 25-29.
119. Kinzfogl, J., G. Hangoc & H.E. Broxmeyer 2011. Neurexin1a/neurexophilin 1 function as a myelosuppressive axis in human cord blood and murine bone marrow hematopoiesis. Blood 118: 565-575.
120. Broxmeyer, H.E. & S. Cooper 1997. High efficiency recovery of immature hematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for ten years. Clin. Exp. Immunol. 107: 45-53.
121. Broxmeyer, H.E., E.F. Srour, G. Hangoc, et al 2003. High efficiency recovery of hematopoietic progenitor cells with extensive proliferative and ex vivo expansion activity and of hematopoietic stem cells with NOD/SCID mouse repopulation ability from human cord blood stored frozen for 15 years. Proc. Natl. Acad. Sci. USA 100: 645-650.
122. Broxmeyer, H.E., M-R. Lee, G. Hangoc, et al 2011. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 117: 4773-4777.